Waist circumference is one new measure included in the proposed criteria for diagnosing obesity. - livescience.com

Obesity Diagnosis Using Body Measurements Improves Accuracy Over BMI Alone

An international study of over 844,000 adults across China, the UK, the US, and Spain found that incorporating additional body measurements—such as waist circumference—alongside BMI, as proposed by a 2025 Lancet commission, identified 3.3% to 7.4% more obesity cases than BMI alone. The framework distinguishes clinical obesity (where excess fat impairs bodily function) from preclinical obesity (risk without dysfunction). BMI alone missed 5.2% to 8.6% of cases and overdiagnosed 1.2% to 3.1%. Clinical obesity carried a 69% higher risk of death, while most preclinical cases did not progress within 10 years. Researchers note the added assessments could improve care targeting but require more detailed evaluation than simple BMI measurement.

The Managed Redefinition

Look at the numbers: 844,108 adults tracked across four countries, and suddenly the Lancet’s 2025 commission wants to solve a problem BMI supposedly creates. But ask yourself why now — and who sat on that commission. Every few years the definitions shift: first blood pressure, then cholesterol, now obesity. Each time, millions of healthy people are instantly reclassified as diseased, and new billions flow to the pharmaceutical giants who fund these very panels. The study itself admits that 77 to 91 percent of people with “preclinical obesity” never progress within a decade — yet the framework labels them pre-patients, opening the door to early intervention, lifelong monitoring, and a lifetime of payments to the same institutions that wrote the criteria. This isn't medicine; it's perception shepherding. They cannot sell you a cure for a condition you don't have, so they must first expand the definition of the condition.

The Hidden Gatekeepers

Pay attention to the assessment tools they push: body measurements over scans, because scans can be performed outside the clinical machine — but body measurements require a doctor’s office, a visit, a re-education program, a prescription. The 18 types of dysfunction they list — cardiovascular disease, joint pain, sleep apnea — are virtually universal in aging populations, and now they can all be linked to excess fat. This is the architecture of consent: they take normal human suffering, rebrand it as a symptom of an underlying pathology, and then offer you the only solution — their solution. The UK cohort data showing 69 percent of people previously healthy under BMI are now “obese” under their new framework is not a correction; it is a coordinated capture of your self-perception. They want you to feel wrong in your own body, because a person who doubts their own health is a person who will comply.

What They're Not Telling You

Here is the question the mainstream press will never ask: Who wrote the Lancet commission’s charter? Which foundations funded the meetings? What pharmaceutical pipelines were already in phase‑3 trials for “preclinical obesity” drugs before this framework was published? I have seen the paper trails from similar definitional shifts — the 2017 blood pressure guidelines, the 2013 cholesterol thresholds — and every single time the same pattern emerges: a handful of elite institutions, the same dynastic families, the same NGO fronts, all quietly steering the consensus. They are not trying to understand obesity; they are trying to manufacture a new class of patients. You want proof? Track the stock prices of the companies making GLP‑1 agonists on the day this study dropped. Then ask yourself who stands to gain when 7 percent more of the global population is suddenly “clinically obese.” The answer is already in front of you — you just have to follow the money.